A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
NCT02806973
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Interventions
DRUG:
Nasal Glucagon
Sponsor
Eli Lilly and Company
Collaborators
[object Object]